Contact Us

US:
+1 866 748 4042
UK:
+44 (0) 207 910 7700
Sweden:
+46 18 431 10 00

Phase I Clinical Facilities

Phase I Clinical Facilities

View images from our facilities in the US, London and Sweden.

View now

Patient and Volunteers Learn More About Clinical Research

Get involved and celebrate the impact you can have on efficient drug development.

Participate in a Trial

Phase I Systems

Phase I Systems

Find out how our Phase I system enables you to make critical decisions earlier.

View now

News

QUINTILES ANNOUNCES CLINICAL PHARMACOLOGY ALLIANCE WITH ASTRAZENECA

November 2, 2009 - Quintiles has entered into in an industry-leading clinical pharmacology alliance with AstraZeneca to deliver AstraZeneca’s clinical pharmacology studies across multiple therapy areas and around the globe.

Read more

QUINTILES TO OPEN PHASE I UNIT IN INDIA

January 27, 2009 – Quintiles Transnational Corp. announced a partnership with Apollo Hospitals Group to open a Phase I clinical trial unit in Hyderabad, India.

Read more

The results are in.

The results are in.

Quintiles has been named the top CRO by two independent surveys. Learn why at the June 2009 DIA Annual Meeting.

More information

Send Us Your RFP

Submit request

Learn more about Phase I/IIa

Phase I/IIa

Promote Safe, Clinically Advanced Phase I/IIa Studies

You need to safely advance your drug candidate through phase I/IIa. The key to achieving this objective – on time – is to focus on maximizing critical data through strategic study design.

With four clinical phase I and phase IIa units in England, Sweden (2) and the United States, we offer:

  • Study units across the globe – operating as one when sharing data and expertise
  • Leading-edge, scientifically stringent analytical and technology solutions
  • Proven study capabilities
    • Complex
    • Regulatory
    • Vaccine

Detail-driven Phase I / Phase IIa Services, Processes and Staff

Together, we determine innovative and adaptive clinical study designs and Phase I/Phase IIA services required to reach your objectives. The result? Accurate, quality data to help you make faster, better informed decisions.

And throughout the study, our experts – leading authorities in early clinical trials phases research – consult and advise you. The impact? You receive the best actionable insight.